Endocrine System Diseases  >>  SAR 161271  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SAR 161271 / Sanofi
NCT01053728: Study of How Single Rising Doses of SAR161271 Are Absorbed and Act in Patients With Type 1 Diabetes Mellitus (T1DM)

Completed
1/2
46
Europe
SAR161271, Insulin glargine HOE901
Sanofi
Type 1 Diabetes Mellitus
05/10
11/10

Download Options